29.01.2020
- Anglo-Swedish drugmaker AstraZeneca plans to invest up to $1 billion in a scheme it calls Ambition Zero Carbon, which as the name suggests is aimed at achieving zero carbon...
17.01.2020
- Japanese drugmaker Takeda is facing a large tax bill from Ireland as an uncalculated repercussion of its acquisition of US-managed, Ireland-domiciled Shire at the end of 2018. Tax...
07.11.2019
- In the largest acquisition in the company’s history, German generics producer Stada is paying $660 million to take some of the over-the-counter and prescription drugs portfolio of...
30.10.2019
- Japan’s Takeda Pharmaceutical has bought an exclusive global license to an investigational therapy for celiac disease from US biotech Cour Pharmaeuticals. Takeda will develop and...
21.10.2019
- In another move to reduce debt after buying Shire early this year, Japanese drugmaker Takeda has agreed to sell roughly 30 prescription pharmaceuticals and over-the-counter (OTC)...
26.09.2019
- German drug discovery and development company Evotec has entered into a strategic, multi-year collaboration with Japan’s Takeda Pharmaceutical that could be worth in excess of $850...
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
13.05.2019
- To lighten its debt burden of more than $30 billion resulting from last year’s acquisition of Shire, Japanese pharma giant Takeda is selling Shire’s dry-eye drug Xiidra to...
